Simplex Trading’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Simplex Trading’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$480K	Buy	6,812 +3,335	+96%	+$204K	﹤0.01%	3612
2026 Q2	$198K	Buy	+3,477	New	+$166K	﹤0.01%	4735
2024 Q4	–	Sell	-44	Closed	-$1K	–	8930
2024 Q3	$1K	Buy	44 +29	+193%	+$1.3K	﹤0.01%	8190
2024 Q2	$0	Buy	+15	New	+$627	﹤0.01%	9152
2022 Q4	–	Sell	-578	Closed	-$29K	–	9613
2022 Q3	$29K	Buy	578 +384	+198%	+$21.7K	﹤0.01%	7104
2022 Q2	$9K	Sell	194 -1,815	-90%	-$92K	﹤0.01%	8364
2022 Q1	$120K	Buy	2,009 +1,890	+1,588%	+$119K	﹤0.01%	5890
2021 Q4	$9K	Sell	119 -3	-2%	-$252	﹤0.01%	9115
2021 Q3	$12K	Hold	122	–	–	﹤0.01%	8815
2021 Q2	$12K	Buy	122 +82	+205%	+$7.27K	﹤0.01%	8979
2021 Q1	$3K	Buy	+40	New	+$3.95K	﹤0.01%	8363

Other funds holding GNOM

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Polaris Financial Partners Westerville, Ohio $223M AUM

Creative Financial Designs Kokomo, Indiana $2.22B AUM 15.38% 1-Year Est. Return

Sightline Wealth Advisors Groton, Connecticut $215M AUM 10.46% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.2B AUM 15.74% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplex Trading's GNOM Position: Q3 2026 in Review

Simplex Trading increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 96% in Q3 2026, buying an estimated $204K and bringing the position to 6,812 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

Simplex Trading first reported a position in GNOM in Q1 2021 and has held it in 11 quarters since. 28 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

Simplex Trading held 6,812 shares of Global X Genomics & Biotechnology ETF worth $480K as of Q3 2026.
Simplex Trading bought 3,335 Global X Genomics & Biotechnology ETF shares in Q3 2026, an estimated $204K.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #3612 holding.
Simplex Trading first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 11 quarters since.
28 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.